Studies have shown that LINC01273 is markedly upregulated in HCC and SOR-resistant tissues, increasing the stability of miR-600 and thus METTL3 mRNA inhibition, thereby leading to METTL3 downregulation and SOR resistance. Here, METTL3 is linked to hepatocellular carcinoma.